Skip to main content
Brain Communications logoLink to Brain Communications
. 2021 Oct 27;3(4):fcab254. doi: 10.1093/braincomms/fcab254

Smaller spared subcortical nuclei are associated with worse post-stroke sensorimotor outcomes in 28 cohorts worldwide

Sook-Lei Liew 1,2,, Artemis Zavaliangos-Petropulu 3,4, Nicolas Schweighofer 5, Neda Jahanshad 4, Catherine E Lang 6,7,8, Keith R Lohse 9, Nerisa Banaj 10, Giuseppe Barisano 3,11, Lee A Baugh 12,13,14,15, Anup K Bhattacharya 16, Bavrina Bigjahan 17, Michael R Borich 18, Lara A Boyd 19, Amy Brodtmann 20,21, Cathrin M Buetefisch 18,22,23, Winston D Byblow 24, Jessica M Cassidy 25, Charalambos C Charalambous 26,27, Valentina Ciullo 10, Adriana B Conforto 28,29, Richard C Craddock 30, Adrienne N Dula 30, Natalia Egorova 20,31, Wuwei Feng 32, Kelene A Fercho 33,34, Chris M Gregory 32, Colleen A Hanlon 35,36, Kathryn S Hayward 20,37,38, Jess A Holguin 1, Brenton Hordacre 39, Darryl H Hwang 17,40, Steven A Kautz 32,41, Mohamed Salah Khlif 20, Bokkyu Kim 42, Hosung Kim 2, Amy Kuceyeski 43, Bethany Lo 1, Jingchun Liu 44, David Lin 45, Martin Lotze 46, Bradley J MacIntosh 47,48, John L Margetis 1, Feroze B Mohamed 49, Jan Egil Nordvik 50, Matthew A Petoe 51,52, Fabrizio Piras 10, Sharmila Raju 53, Ander Ramos-Murguialday 54,55, Kate P Revill 56, Pamela Roberts 1,57,58, Andrew D Robertson 59,60, Heidi M Schambra 53, Na Jin Seo 32,41,61, Mark S Shiroishi 4,17, Surjo R Soekadar 62, Gianfranco Spalletta 10,63, Cathy M Stinear 64, Anisha Suri 65, Wai Kwong Tang 66, Gregory T Thielman 67, Vincent N Thijs 20,68, Daniela Vecchio 10, Nick S Ward 69, Lars T Westlye 70,71, Carolee J Winstein 5,72, George F Wittenberg 73,74, Kristin A Wong 75, Chunshui Yu 44,76, Steven L Wolf 77,78,79,80,81, Steven C Cramer 58,72, Paul M Thompson 4; ENIGMA Stroke Recovery Working Group 1
PMCID: PMC8598999  PMID: 34805997

Abstract

Up to two-thirds of stroke survivors experience persistent sensorimotor impairments. Recovery relies on the integrity of spared brain areas to compensate for damaged tissue. Deep grey matter structures play a critical role in the control and regulation of sensorimotor circuits. The goal of this work is to identify associations between volumes of spared subcortical nuclei and sensorimotor behaviour at different timepoints after stroke. We pooled high-resolution T1-weighted MRI brain scans and behavioural data in 828 individuals with unilateral stroke from 28 cohorts worldwide. Cross-sectional analyses using linear mixed-effects models related post-stroke sensorimotor behaviour to non-lesioned subcortical volumes (Bonferroni-corrected, P < 0.004). We tested subacute (≤90 days) and chronic (≥180 days) stroke subgroups separately, with exploratory analyses in early stroke (≤21 days) and across all time. Sub-analyses in chronic stroke were also performed based on class of sensorimotor deficits (impairment, activity limitations) and side of lesioned hemisphere. Worse sensorimotor behaviour was associated with a smaller ipsilesional thalamic volume in both early (n = 179; d =0.68) and subacute (n = 274, d =0.46) stroke. In chronic stroke (n = 404), worse sensorimotor behaviour was associated with smaller ipsilesional putamen (d =0.52) and nucleus accumbens (d =0.39) volumes, and a larger ipsilesional lateral ventricle (d =−0.42). Worse chronic sensorimotor impairment specifically (measured by the Fugl-Meyer Assessment; n = 256) was associated with smaller ipsilesional putamen (d =0.72) and larger lateral ventricle (d = −0.41) volumes, while several measures of activity limitations (n = 116) showed no significant relationships. In the full cohort across all time (n = 828), sensorimotor behaviour was associated with the volumes of the ipsilesional nucleus accumbens (d =0.23), putamen (d =0.33), thalamus (d =0.33) and lateral ventricle (d = −0.23). We demonstrate significant relationships between post-stroke sensorimotor behaviour and reduced volumes of deep grey matter structures that were spared by stroke, which differ by time and class of sensorimotor measure. These findings provide additional insight into how different cortico-thalamo-striatal circuits support post-stroke sensorimotor outcomes.

Keywords: stroke, rehabilitation, sensorimotor behaviour, MRI, subcortical volumes


Liew et al. report the first large-scale examination using high-resolution neuroimaging of subcortical nuclei and sensorimotor behaviour in 828 stroke patients from 28 cohorts worldwide. They discovered novel associations between post-stroke sensorimotor behaviour and specific subcortical nuclei, providing new insight for stroke rehabilitation.

Graphical Abstract

Graphical Abstract.

Graphical Abstract

Introduction

Sensorimotor recovery after stroke relies on residual motor architecture.1 The majority of research in this area has focused on the role of cortical regions within sensorimotor networks, which often undergo significant reorganization and vary widely across individuals after stroke. Spared subcortical nuclei also form key components of corticothalamic and corticostriatal circuits that support sensorimotor performance but have been less studied in recent years. These structures may yield additional insight into processes impacting stroke outcomes, given their clearly defined boundaries, well-mapped inputs and outputs, and known associations with specific neurotransmitters and genetic variants.2

As relay nodes for sensorimotor circuits in the brain, subcortical nuclei not only play a critical role in the maintenance and regulation of networks for motor learning, but they also subserve cognition, metabolic regulation, and reward—all of which have been implicated as contributors to post-stroke outcomes, including sensorimotor functioning and recovery.3–6 Each structure in the cortico-striatal-thalamic circuit has a distinct role in sensorimotor control and possibly outcomes. For instance, the thalamus is integral to the regulation of metabolism, sleep and wakefulness, cognitive processing, and integrating sensorimotor information,7 and thalamic metabolism has been shown to be disordered in the early weeks after stroke.3,8 Similarly, the basal ganglia (e.g. caudate, putamen, globus pallidus, and nucleus accumbens) are heavily involved in motor control, learning and reward, with distinct roles for each nuclei.9,10 Direct damage to the thalamus and basal ganglia is associated with poor sensorimotor behaviour and recovery,4,11 but the role of each spared subcortical nuclei is unclear.

To date, these subcortical structures have been studied only in modestly-sized samples, with varying results, and with measurements from multiple regions often aggregated as one (e.g. combined analysis of the thalamus and basal ganglia). However, each nucleus has a characteristic distribution of neurotransmitters and network connections; identifying specific non-lesioned subcortical nuclei could provide more precise neurobiological targets for therapeutics to potentiate recovery.

In addition, inter-individual variability and the heterogeneity of brain changes after stroke pose challenges to the identification of neural targets in spared tissue. Addressing this issue requires large, diverse, and appropriately powered sample sizes with high-resolution brain MRIs. Although acute stroke research has successfully utilized pooled approaches with individual patient data to examine acute treatment outcomes,12,13 stroke rehabilitation research has been slower to adopt this type of approach due to the complexity of combining elaborate rehabilitation research protocols, differences in the site and size of infarcts, diversity of the patient populations recruited, and variety of the stroke neuroimaging and behavioural measures collected. To address these challenges, we formed an international Stroke Recovery Working Group through the Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Consortium to harmonize and combine diverse individual patient data, including high-resolution structural brain MRIs and behavioural outcome measures, across multiple research centres.14 Our ENIGMA Stroke Recovery Working Group pools individual patient data across research sites using a harmonized analytical pipeline and includes both published and unpublished data. Compared to traditional single-site analyses or retrospective meta-analyses, this approach allows for greater statistical rigour, testing of more sophisticated hypotheses (e.g. subgroup analyses), and less bias due to the inclusion of both published and unpublished data across diverse cohorts.15,16 Furthermore, pooled analyses with multi-site data increase heterogeneity, which improves generalizability of findings, reduces research inefficiency by leveraging previously collected data to examine novel questions, and advances the field faster than is achievable by prospective studies.17

The current study pools data from 828 individuals across 28 cohorts worldwide from the ENIGMA Stroke Recovery Working Group to examine relationships between sensorimotor behavioural measures and volumes of the ipsilesional and contralesional thalamus, putamen, caudate, pallidum and nucleus accumbens. Enlargement of the lateral ventricles was also examined as an indirect measure of atrophy and vascular integrity.18,19 Given the neurobiological events unique to early and subacute stroke compared to chronic stroke, data were analysed separately for individuals in the subacute (≤90 days) and chronic (≥180 days) stages.20 As an exploratory measure, we also analysed relationships early after stroke (≤21 days), before post-stroke secondary structural atrophy is thought to be observed,21 to estimate whether subacute associations are driven by early post-stroke changes or likely existed prior to the stroke, as well as across all time.

We hypothesized that thalamic volume would relate to sensorimotor behaviour in early and subacute phases after stroke, given its multiple roles in supporting cellular repair.3,22 We further expected that smaller subcortical volumes (reflecting atrophy of structures associated with sensorimotor control) and larger ventricles (reflecting general atrophy) would be related to worse chronic sensorimotor behaviour.23

Furthermore, as sensorimotor behaviour encompasses multiple classes of the International Classification of Functioning, Disability, and Health (ICF), we conducted separate subgroup analyses in chronic stroke to examine if there are specific neural correlates of loss of body structures and function (i.e. sensorimotor impairment) versus loss of activity in daily tasks (i.e. activity limitations).24 We anticipated that subcortical nuclei important for direct sensorimotor control, such as the putamen, would more strongly relate to impairment; conversely, regions associated with reward and motivation, such as the nucleus accumbens, should more strongly relate to activity limitation. Finally, in chronic stroke, we also examined the impact of the side of the lesion. Based on evidence of hemispheric specialization for motor behaviour after stroke,25 we hypothesized that the side of the lesion would modify the relationship between non-lesioned subcortical tissue volume and sensorimotor behaviour.

Materials and methods

Study design

The current cross-sectional pooled analysis used data from the ENIGMA Stroke Recovery Working Group, which was frozen for this analysis on 22 May 2020. A detailed overview of ENIGMA Stroke Recovery procedures and methods are reported elsewhere.14 The retrospective data were collected across 28 different research studies (i.e. cohorts) at 16 different research institutes in 10 countries. Data were collected in accordance with the Declaration of Helsinki and in compliance with local ethics review boards at each institute (see Supplementary Table 1 for details).

ENIGMA stroke recovery dataset

Participants with at least one sensorimotor behavioural outcome measure (see Behavioural Data Analysis) and a segmented high-resolution (e.g. 1-mm isotropic) T1-weighted (T1w) structural MRI of the brain (see MRI data analysis) were included, yielding an initial dataset of 1285 individuals. Only participants with unilateral ischaemic stroke or intracerebral haemorrhage in subcortical and/or cortical regions were included, while individuals identified as having bilateral lesions or lesions in the brainstem or cerebellum were excluded from this analysis. For any longitudinal observations, only the first time-point was used; the resulting dataset was therefore cross-sectional. Each brain region was manually inspected for quality and overlap with the lesion (see MRI data analysis). Any individuals missing covariates of age (n = 50) or sex (n = 89) were also excluded, yielding a final sample of 828 individuals. As the relationships between brain volume and sensorimotor behaviour were expected to change with time after stroke, the data were divided into subacute stroke (≤90 days post-stroke) and chronic stroke (≥180 days post-stroke). Exploratory analyses looking only at early stroke (≤21 days post-stroke) and across all times after stroke are also included.

MRI data analysis

To extract subcortical volumes, the brain imaging software package FreeSurfer (version 5.3) was used to segment subcortical regions of interest (ROIs) from the T1w MRIs.26 Twelve ROIs were extracted: the left and right thalamus, caudate, putamen, pallidum, nucleus accumbens and lateral ventricles. For all analyses, these were characterized as ipsilesional and contralesional with respect to the lesioned hemisphere. Total intracranial volume (ICV) was also quantified using FreeSurfer outputs. ENIGMA scripts developed in-house were used to extract the volume of each ROI for each individual and to generate quality control triplanar images of each segmented ROI as done previously (http://enigma.ini.usc.edu/protocols/).2 Given the variability of post-stroke neuroanatomy following a lesion, trained research team members (A.Z.-P., A.S.) performed visual quality control for each ROI in each subject. Any regions intersecting the lesion were marked ‘lesioned’, and any regions not properly segmented by FreeSurfer were marked ‘failed’. Regions falling in either category were excluded from further analysis (for the full quality control protocol, see Appendix 1 in ref 14). Sample sizes for each analysis and brain region are reported in each results table.

Behavioural data analysis

Across cohorts, behavioural data were collected within approximately 72 h of the MRI. To maximize the utility of the full dataset, a primary sensorimotorbehaviourscore was defined for each study cohort using the standardized measure reported by that cohort which was most commonly represented in the dataset overall (see Supplementary materials). In order to aggregate the different measures across cohorts, for each measure, a fraction of the maximum possible score was calculated, such that 0 represented the worst sensorimotor performance (severe deficits) and 1 represented the best sensorimotor performance (no deficits). For example, the most common measure used across cohorts was the Fugl-Meyer Motor Assessment of Upper Extremities (FMA-UE),27 and a score of 45 out of the maximum 66 possible points on this assessment would be represented as 0.68.

In chronic stroke, we also examined behavioural measures that specifically captured impairment and activity limitation. Impairment was measured by the FMA-UE, whereas activity limitation was measured by the Action Research Arm Test (ARAT)28 and Wolf Motor Function Test (WMFT).29 These data were not examined in early stroke due to the limited sample sizes with these measures.

Statistical analysis

To examine the relationships between sensorimotor behaviour and non-lesioned subcortical volumes, we performed linear mixed-effects regressions. A separate regression model was run for the volume of each subcortical ROI (outcome) using sensorimotor behaviour (e.g. primary sensorimotor behaviour score, sensorimotor impairment, or activity limitations) as the primary predictor of interest. After ruling out collinearity (variance inflation factor ≤ 2.5), normalized age, ICV, and sex were included as fixed effects. Research cohort was included as a random effect. In chronic stroke, the effect of lesioned hemisphere was examined by including an interaction term between sensorimotor behaviour and side of lesioned hemisphere to the model predicting subcortical volume. This was not examined in subacute stroke due to the smaller sample size. A likelihood ratio test was performed to compare models with and without random effects and showed that the random effects were always significant. The regression assumptions of linearity, normality of the residuals, and homogeneity of the residual variance were checked via visual inspection of residuals versus fits plots as well as qq-plots for both individual observations and research cohorts. Potential influential values for both observations and cohorts were assessed using Cook’s distance with recommended thresholds.30 As we detected influential observations in almost all analyses, we re-ran the analyses using robust mixed-effect regression, which reduces the weight of influential observations in the models without excluding data.31 Results did not differ between original and robust regression models. The results of the robust regression models can be found in Supplementary materials.

For all regression analyses, beta coefficients are presented for the predictor of interest (e.g. sensorimotor behaviour, sensorimotor impairment, or activity limitations), along with the sample size (n), standard error (SE), 95% confidence interval (CI), degrees of freedom (df), standardized effect size (d), t-value and uncorrected P-value. Statistical significance was adjusted for multiple comparisons across the 12 ROIs using a Bonferroni correction (P < 0.004). Any significant fixed covariates are also reported.

We also compared sensorimotor behaviour scores between left and right hemisphere stroke groups. The data violated the Wilk–Shapiro test of normality for both groups (LHS: W = 0.89, P < 0.001, RHS: W = 0.89, P < 0.001). We therefore used a nonparametric Wilcoxon rank sum test to compare independent group samples.

All statistical analyses were conducted in R (version 3.6.3; R Core Team, 2020).32 The follow R libraries were used for the statistical analyses: the lme function from nmle was used for the linear mixed-effects regressions,33 the rlmer function from robustlmm was used for the robust linear mixed-effects regressions,34 and the rstatix library was used for the Wilcoxon rank sum test.35 In addition, influence. ME was used to detect influential values36 and dplyr37 and tidyverse38 libraries were used for data organization.

Data availability

The deidentified summary data and code that support the findings of this study are available upon reasonable request from the corresponding author. The data are not all publicly available in a repository as they may contain information that could compromise the privacy of research participants. There are also data sharing restrictions imposed by some of the (i) ethical review boards of the participating sites, and consent documents; (ii) national and trans-national data sharing laws; and (iii) institutional processes, some of which require a signed data transfer agreement for limited and predefined data use. However, we welcome sharing data with researchers, requiring that they become members of the ENIGMA Stroke Recovery working group and submit an analysis plan for a secondary project for group review. Once this analysis plan is approved, access to the relevant data will be provided contingent on data availability, local PI approval and compliance with all supervening regulatory boards.

Results

Data from 828 individuals across 28 cohorts worldwide were included (see Table  1 for an overview of cohort characteristics). Briefly, the median age was 63 years old (interquartile range (IQR) 19 years), and there were 516 males and 312 females.

Table 1.

Summary of research cohort characteristics

Cohort ID n Females/Males Median age (IQR, min–max) Median sensorimotor score (IQR, min–max)
1 39 10/29 61 (17, 31–80) 0.65 (0.23, 0.0–0.9)
2 12 06/06 70 (12, 39–85) 0.50 (0.41, 0.2–0.7)
3 14 06/08 60 (15, 33–85) 0.25 (0.22, 0.1–0.6)
4 19 06/13 44 (15, 30–68) 0.14 (0.17, 0.0–0.5)
7 42 14/28 56 (14, 18–80) 0.82 (0.35, 0.4–1.0)
8 8 02/06 62 (10, 39–75) 0.55 (0.35, 0.0–1.0)
9 93 29/64 70 (16, 24–88) 1.00 (0.07, 0.0–1.0)
10 24 05/19 59 (13, 42–74) 1.00 (0.02, 0.7–1.0)
11 29 10/19 57 (11, 44–71) 1.00 (0.05, 0.1–1.0)
12 57 31/26 71 (17, 31–97) 0.65 (0.71, 0.0–1.0)
13 44 22/22 72 (18, 33–91) 0.12 (0.32, 0.0–1.0)
15 14 06/08 57 (11, 45–74) 0.72 (0.25, 0.4–0.8)
17 16 05/11 59 (04, 45–68) 0.55 (0.23, 0.2–0.7)
18 11 05/06 59 (07, 46–73) 0.65 (0.22, 0.5–0.9)
19 13 03/10 62 (21, 33–74) 0.84 (0.08, 0.8–0.9)
20 22 08/14 70 (13, 49–79) 0.91 (0.14, 0.3–1.0)
22 17 04/13 59 (30, 25–72) 0.63 (0.50, 0.0–0.8)
23 13 07/06 58 (08, 31–90) 0.42 (0.17, 0.3–0.8)
24 21 11/10 63 (13, 32–78) 0.95 (0.00, 0.6–1.0)
25 26 10/16 65 (18, 37–88) 0.97 (0.20, 0.0–1.0)
26 24 14/10 49 (20, 25–71) 0.64 (0.14, 0.3–0.8)
28 26 07/19 62 (11, 23–75) 0.75 (0.25, 0.3–1.0)
31 35 09/26 58 (12, 21–86) 0.52 (0.31, 0.2–0.9)
32 7 03/04 62 (16, 38–72) 0.95 (0.44, 0.2–1.0)
34 15 06/09 58 (11, 32–80) 0.82 (0.20, 0.6–1.0)
35 15 06/09 64 (18, 31–83) 0.64 (0.52, 0.2–0.9)
38 81 34/47 66 (19, 30–89) 0.85 (0.60, 0.0–1.0)
41 91 33/58 70 (15, 32–89) 1.00 (0.02, 0.8–1.0)
Total 828 312/516 63 (19, 18–97) 0.82 (0.48, 0–1)

Age and sensorimotor behavioural score data are shown as median [interquartile range (IQR), minimum–maximum values].

In subacute stroke (≤90 days; n = 274), worse post-stroke sens orimotor behaviour was significantly associated with smaller volumes of the ipsilesional thalamus (n = 274, d =0.46, P = 0.002; Table  2; Fig.  1). Analysis of only individuals within just the first 21 days post-stroke (n = 179, d =0.68, P < 0.001) demonstrated the same result with a stronger effect (Table  2).

Table 2.

Relationships between non-lesioned subcortical volumes and sensorimotor behaviour in subacute and early stroke

Subacute and early stroke
Brain region n Beta (CI) SE df t-value P-value d Significant covariates
Subacute stroke (≤90 days)
 Ipsilesional
  Caudate 194 −0.01 (−0.51 to 0.48) 0.25 180 −0.06 0.954 −0.01 ICV
  Lateral ventricle 274 0.18 (−0.14 to 0.51) 0.16 259 1.13 0.258 0.14 Age, ICV
  Nucleus accumbens 245 0.24 (−0.14 to 0.62) 0.19 231 1.26 0.210 0.17 Age
  Pallidum 223 0.21 (−0.26 to 0.67) 0.24 209 0.87 0.387 0.12 ICV
  Putamen 201 0.39 (−0.09 to 0.88) 0.25 187 1.61 0.109 0.24 Age, ICV
  Thalamus 210 0.69 (0.27–1.11) 0.21 197 3.21 0.002 0.46 Age, ICV
 Contralesional
  Caudate 219 0.22 (−0.20 to 0.64) 0.21 205 1.04 0.298 0.15 ICV
  Lateral ventricle 274 0.15 (−0.18 to 0.49) 0.17 259 0.92 0.361 0.11 Age, ICV
  Nucleus accumbens 253 0.15 (−0.23 to 0.52) 0.19 239 0.77 0.443 0.10 Age, ICV
  Pallidum 250 0.50 (0.07–0.92) 0.22 236 2.30 0.022 0.30 ICV
  Putamen 229 0.37 (−0.05 to 0.79) 0.21 215 1.75 0.081 0.24 Age, ICV
  Thalamus 217 0.09 (−0.33 to 0.50) 0.21 204 0.41 0.679 0.06 Age, ICV
Early stroke (≤21 days)
 Ipsilesional
  Caudate 135 −0.09 (−0.67 to 0.48) 0.29 125 −0.32 0.749 −0.06 ICV
  Lateral ventricle 182 0.25 (−0.11 to 0.61) 0.18 172 1.37 0.173 0.21 Age, ICV
  Nucleus accumbens 165 0.19 (−0.23 to 0.60) 0.21 155 0.90 0.369 0.14 Age
  Pallidum 157 0.12 (−0.39 to 0.63) 0.26 147 0.46 0.644 0.08 ICV
  Putamen 143 0.25 (−0.28 to 0.79) 0.27 133 0.93 0.354 0.16 Age, ICV
  Thalamus 137 0.79 (0.38–1.20) 0.21 128 3.82 <0.001 0.68 Age, ICV
 Contralesional
  Caudate 147 0.17 (−0.29 to 0.64) 0.24 137 0.74 0.461 0.13 ICV
  Lateral ventricle 182 0.19 (−0.20 to 0.57) 0.19 172 0.96 0.337 0.15 Age, ICV
  Nucleus accumbens 170 0.30 (−0.09 to 0.69) 0.20 160 1.53 0.127 0.24 Age
  Pallidum 171 0.65 (0.19–1.11) 0.23 161 2.79 0.006 0.44 ICV
  Putamen 158 0.26 (−0.21 to 0.72) 0.24 148 1.10 0.274 0.18 Age, ICV
  Thalamus 150 0.20 (−0.28 to 0.67) 0.24 141 0.82 0.411 0.14 Age, ICV

Results from linear mixed-effects models of individuals with subacute stroke (top) and early stroke (bottom). Results in bold indicate significance with a Bonferroni correction for multiple comparisons (P < 0.004). The beta coefficient for sensorimotor behaviour (beta) with 95% confidence interval (CI), along with the sample size (n), standard error (SE), degrees of freedom (df), standardized effect size (d), t-value and uncorrected P-value are reported, in addition to significant fixed covariates, including age, sex and intracranial volume (ICV).

Figure 1.

Figure 1

Relationships between post-stroke sensorimotor behaviour and non-lesioned subcortical volumes. Non-lesioned subcortical regions (D, bottom right) that relate to sensorimotor behaviour from linear mixed-effects models of people with subacute (A, top left) and chronic (B, bottom left) stroke. Non-lesioned subcortical volume relationships with chronic sensorimotor impairment are shown in C (top right). There were no significant volume relationships with chronic activity limitations. Colours represent the beta estimate (β) for sensorimotor behaviour from each model. Warmer colours represent stronger positive relationships (e.g. larger brain volumes relate to better behaviour), and cooler colours represent stronger negative relationships (e.g. larger brain volumes relate to worse behaviour).

In chronic stroke (≥180 days; n = 404), worse sensorimotor behaviour was related to smaller volumes of the ipsilesional putamen (d =0.52, P < 0.001) and ipsilesional nucleus accumbens (d =0.39, P = 0.002), and a larger volume of the ipsilesional lateral ventricle (d = −0.42, p < 0.001; Table  3; Fig.  1).

Table 3.

Relationships between non-lesioned subcortical volumes and sensorimotor behaviour in chronic stroke

Chronic stroke
Chronic stroke (≥180 days)
Brain region n Beta (CI) SE df t-value P-value d Significant covariates
Ipsilesional
 Caudate 193 0.27 (−0.28 to 0.82) 0.28 169 0.98 0.330 0.15 ICV
Lateral ventricle 404 −0.70 (−1.04 to 0.36) 0.17 378 −4.04 <0.001 −0.42 Age, ICV
Nucleus accumbens 289 0.72 (0.27–1.18) 0.23 264 3.15 0.002 0.39 Age
 Pallidum 225 0.30 (−0.23 to 0.84) 0.27 200 1.11 0.267 0.16 ICV
Putamen 207 1.01 (0.45–1.57) 0.28 183 3.54 <0.001 0.52 Age
 Thalamus 169 0.08 (−0.60 to 0.75) 0.34 146 0.22 0.827 0.04 Age
Contralesional
 Caudate 345 0.08 (−0.31 to 0.48) 0.20 320 0.41 0.679 0.05 ICV
 Lateral ventricle 404 −0.39 (−0.70 to 0.07) 0.16 378 −2.42 0.016 −0.25 Age, ICV
 Nucleus accumbens 344 0.21 (−0.22 to 0.65) 0.22 319 0.96 0.339 0.11 Age
 Pallidum 359 0.20 (−0.20 to 0.60) 0.20 334 0.97 0.332 0.11 Sex, ICV
 Putamen 355 0.21 (−0.18 to 0.60) 0.20 330 1.06 0.291 0.12 Age, ICV
 Thalamus 329 −0.24 (−0.60 to 0.12) 0.18 304 −1.29 0.196 −0.15 Age, ICV

Results from linear mixed-effects models of individuals with chronic stroke. Results in bold indicate significance with a Bonferroni correction for multiple comparisons (P < 0.004). The beta coefficient for sensorimotor behaviour (beta) with 95% confidence interval (CI), along with the sample size (n), standard error (SE), degrees of freedom (df), standardized effect size (d), t-value and uncorrected P-value are reported, in addition to significant fixed covariates, including age, sex and intracranial volume (ICV).

In chronic stroke, we examined brain–behaviour relationships using a measure of impairment (the FMA-UE scale; n = 256) and two measures of activity limitation (WMFT, ARAT; n = 116). Worse sensorimotor impairment was associated with smaller ipsilesional putamen (d =0.72, P = 0.001) and larger ipsilesional lateral ventricle volumes (d = −0.41, P = 0.002; Table  4; Fig.  1). We found no significant relationships between subcortical volumes and measures of activity limitations (Table  4).

Table 4.

Relationships between non-lesioned subcortical volumes and two measures of sensorimotor behaviour (impairment, activity limitations)

Chronic sensorimotor impairment and activity limitations
Brain region n Beta (CI) SE df t-value P-value d Significant covariates
Sensorimotor impairment in chronic stroke
 Ipsilesional
  Caudate 94 0.92 (−0.06 to 1.89) 0.49 77 1.87 0.065 0.43 ICV
  Lateral ventricle 256 −0.74 (−1.20 to 0.27) 0.24 237 3.13 0.002 0.41 Age, ICV
  Nucleus accumbens 171 0.58 (0.01–1.15) 0.29 153 2.02 0.045 0.33 Age
  Pallidum 120 0.76 (0.01–1.51) 0.38 102 2.02 0.046 0.40
  Putamen 104 1.50 (0.61–2.39) 0.45 87 3.34 0.001 0.72
  Thalamus 84 0.33 (−0.72 to 1.38) 0.53 68 0.62 0.537 0.15
 Contralesional
  Caudate 222 0.06 (−0.44 to 0.57) 0.26 204 0.25 0.806 0.03 ICV
  Lateral ventricle 256 −0.51 (−0.88 to 0.14) 0.19 237 −2.70 0.007 −0.35 Age, ICV
  Nucleus accumbens 222 0.21 (−0.31 to 0.73) 0.26 204 0.80 0.425 0.11 Age
  Pallidum 231 0.20 (−0.33 to 0.73) 0.27 213 0.74 0.459 0.10 Sex
  Putamen 229 0.10 (−0.38 to 0.58) 0.24 211 0.41 0.681 0.06 Age, ICV
  Thalamus 211 −0.40 (−0.88 to 0.07) 0.24 193 −1.67 0.096 −0.24 Age, ICV
Activity limitations in chronic stroke
 Ipsilesional
  Caudate 52 −0.63 (−1.80 to 0.53) 0.58 44 −1.09 0.280 −0.33
  Lateral ventricle 116 −0.71 (−1.46 to 0.04) 0.38 108 −1.88 0.062 −0.36 Age, ICV
  Nucleus accumbens 86 0.77 (−0.31 to 1.85) 0.54 78 1.42 0.159 0.32
  Pallidum 64 0.71 (−0.25 to 1.67) 0.48 56 1.47 0.146 0.39
  Putamen 65 0.71 (−0.62 to 2.04) 0.67 57 1.06 0.292 0.28
  Thalamus 56 0.94 (−0.36 to 2.25) 0.65 48 1.45 0.153 0.42
 Contralesional
  Caudate 96 −0.07 (−0.98 to 0.84) 0.46 88 −0.15 0.885 −0.03
  Lateral ventricle 116 −0.72 (−1.44 to 0.01) 0.37 108 −1.95 0.054 −0.38 Age, ICV
  Nucleus accumbens 107 −0.34 (−1.17 to 0.49) 0.42 99 −0.81 0.420 −0.16 Age
  Pallidum 103 −0.15 (−0.98 to 0.68) 0.42 95 −0.35 0.728 −0.07 Sex
  Putamen 100 0.06 (−0.91 to 1.03) 0.49 92 0.12 0.903 0.03 Age
 Thalamus 92 0.28 (−0.51 to 1.06) 0.39 84 0.71 0.482 0.15 Age, ICV

Results from linear mixed-effects models in individuals with chronic stroke of sensorimotor impairment (top) compared to activity limitations (bottom). Results in bold indicate significance with a Bonferroni correction for multiple comparisons (P < 0.004). The beta coefficient for sensorimotor impairment/activity limitations (beta) with 95% confidence interval (CI), along with the sample size (n), standard error (SE), degrees of freedom (df), standardized effect size (d), t-value, and uncorrected P-value are reported, in addition to significant fixed covariates, including age, sex and intracranial volume (ICV).

In chronic stroke, we further analysed the differences between individuals with left hemisphere stroke (LHS, n = 214) versus right hemisphere stroke (RHS, n = 190) by including lesioned hemisphere as an interaction term in the model. There were no significant effects of the side of the lesioned hemisphere on the relationship between sensorimotor behaviour and subcortical volumes, and no main effects of the lesioned hemisphere (see Supplementary material). Inclusion of the lesioned hemisphere into the model did not change the main effects of sensorimotor behaviour. We also examined whether there were differences in behavioural scores for LHS and RHS groups. The median sensorimotor behaviour score in LHS was 0.80 (IQR = 0.39) and in RHS was 0.74 (IQR = 0.49). A Wilcoxon test showed no significant effect of lesioned hemisphere between groups (P = 0.29, effect size r = 0.053).

Finally, an exploratory analysis of the entire cohort (N = 828) demonstrated significant relationships between worse sensorimotor behaviour and smaller volumes of the ipsilesional thalamus (d =0.33, P = 0.001), putamen (d =0.33, P < 0.001), and nucleus accumbens (d =0.23, P = 0.004), and a larger lateral ventricle volume (d = −0.23, P = 0.001; see Supplementary materials).

Discussion

We report the first international, multi-site pooled analysis with individual patient data using high-resolution structural brain imaging in stroke rehabilitation research and the largest study to date relating spared subcortical brain volumes to post-stroke sensorimotor behaviour. We identified novel, significant relationships between worse post-stroke sensorimotor behaviour and smaller volumes of spared deep grey matter structures, including the ipsilesional thalamus, putamen, and nucleus accumbens, as well as general atrophy as indexed by enlargement of the ipsilesional lateral ventricle. Notably, analyses included only non-lesioned structures, and significant relationships were found only in the ipsilesional hemisphere. These findings suggest that, post-stroke, secondary subcortical brain alterations related to sensorimotor behaviour occur most prominently in the hemisphere directly affected by the stroke. This was observed despite the fact that, after stroke, atrophy and reorganization has been observed bilaterally.39 The identification of sensorimotor relationships with these specific ipsilesional subcortical nuclei may provide novel targets to improve stroke outcomes.

Our results support the hypothesis that different non-lesioned deep grey structures serve distinct roles in subacute versus chronic stroke, which is not surprising given the cascade of neurobiological and neuroinflammatory processes that occur early after stroke.40,41 Within 90 days after stroke, only the ipsilesional thalamus showed detectable associations with post-stroke sensorimotor behaviour, in line with recent research showing marked thalamic atrophy, especially within the first three months post-stroke.39 A smaller thalamic volume could reflect cell loss and thalamic dysfunction, thereby limiting resources crucial for early recovery.4,39 Importantly, we found that this relationship is not only present but stronger in the first 21 days post-stroke. As non-lesioned brain volumes within 6 weeks after stroke are assumed to be similar to those before the stroke,21 this finding suggests that larger thalamic volumes prior to stroke could provide a neuroprotective effect. Thalamic atrophy was recently associated with loss of extrinsic and intrinsic connectivity between the thalamus and the rest of the brain, suggesting that thalamic measures may serve as an index of global brain function.42 Future research using longitudinal datasets with greater spatial specificity could relate changes in specific thalamic nuclei to sensorimotor recovery to identify targets for neuroprotective or early stroke therapies.

Although further research is needed to pinpoint which thalamic nuclei are specifically involved with sensorimotor deficits reported here, we hypothesize that nuclei involved in motor (e.g. ventral anterior nucleus, ventrolateral nucleus), sensory (e.g. ventral posteromedial nucleus, ventral posterolateral nucleus), as well as higher order thalamic regions such as the lateral posterior nucleus, which is involved in integrating sensory input with cognitive functions, should be related. Finally, a critical line of future research is the evaluation of isolated thalamic infarctions due to small arterial vessel disease and the possible relationship between these infarctions and post-stroke sensorimotor behaviour.43

In chronic stroke, reduced volumes of the ipsilesional putamen and nucleus accumbens were consistently associated with worse sensorimotor behaviour. General atrophy, as indexed by a larger ipsilesional ventricle volume, was also negatively associated with sensorimotor behavioural measures. This is the first large-scale validation showing volume of these specific structures as correlates of sensorimotor behavioural outcomes in chronic stroke. This finding augments existing stroke literature, which has typically examined direct damage to combine subcortical regions, without differentiating roles of the individual basal ganglia nuclei and thalamus. Here, we specifically identify the putamen and nucleus accumbens, which are key components of corticostriatal and mesolimbic circuits, and which both represent key dopaminergic targets in the brain.

Specifically, within the corticostriatal circuit, the putamen receives direct cortical signals from the primary motor, premotor, and sensory cortices and relays them to the thalamus to modulate motor control. Interestingly, although the caudate also relays input to the thalamus, it receives its inputs from multimodal association cortices and visual regions—not primary motor regions—and did not have a significant brain–behaviour relationship in our analyses. This distinction suggests that post-stroke sensorimotor behaviour is primarily associated with subcortical nuclei specifically receiving direct sensorimotor input. In line with this, we found that smaller putamen volumes related to both worse sensorimotor behaviour generally and impairment specifically, as evidenced by the association with the FMA-UE in chronic stroke. This finding is in line with previous work showing that direct damage to the putamen relates to post-stroke gait impairment,44 upper limb impairment45 and spasticity,46 all deficits which overlap with the behavioural measures used here. In addition, secondary atrophy of the putamen has been reported after cortical stroke and is associated with infarct volume47 and post-stroke cognitive deficits.48 The relationship between chronic sensorimotor behavioural deficits and atrophy of the ipsilesional putamen after stroke, however, has not previously been reported. As atrophy of the putamen has been associated with a wide variety of neuropsychiatric and neurodegenerative disorders,49 including Alzheimer’s disease,50 multiple sclerosis, attention deficit disorder12 and Huntington’s disease,10 it is possible that the integrity of the putamen is required not only for specifically sensorimotor behaviour but also, more generally, for overall healthy brain functioning.

While the ipsilesional nucleus accumbens was significantly related to chronic sensorimotor behaviour in general, it was neither related to sensorimotor impairment (FMA-UE) nor to activity limitation. However, the analyses on impairment and activity limitations had less statistical power to detect relationships. The nucleus accumbens is a key component of the ventral striatum and implicated in fear, stress, and anxiety disorders51 as well as the dopaminergic modulation of reward-based behaviours.52 As such, this region may impact more complex aspects of motor performance, such as motivation, engagement, and participation, which may not be reflected in metrics of impairment or activity. A number of studies show decreases in ventral striatal processes such as reward sensitivity, motivation, and apathy after stroke,53 and post-stroke hypoactivity in the nucleus accumbens has been identified during reward-based decision-making tasks.54 Thus the nucleus accumbens may affect sensorimotor behaviour by influencing reward and motivation,55 which could impact use of the affected limb in daily tasks. Pharmacological methods to modulate the dopaminergic system and promote motor recovery following stroke have been widely studied, with dopamine expected to influence multiple domains of behaviour, including motor control, motor learning and affective disorders. However, individual outcomes from pharmacological methods vary widely.56 Future research may investigate whether individual differences in the volume and connectivity of the nucleus accumbens predict who may benefit from dopaminergic treatment.

In chronic stroke, we also detected an association between an enlarged ipsilesional lateral ventricle and poor sensorimotor behaviour. This relationship was only significant at the chronic stage and was exclusive to the ipsilesional lateral ventricle, which may be due to hydrocephalus ex vacuo. Ventricular enlargement post-stroke may also be influenced by small vessel disease (i.e. leukoaraiosis), although this is typically observed bilaterally.19 Enlargement of the bilateral lateral ventricles has also been associated with generalized brain atrophy that occurs during ageing and with impaired cognitive function.57 The contrast between ipsilesional and contralesional ventricles may provide unique insight into the specific impact of the stroke versus general ageing on chronic stroke sensorimotor outcomes.

Our results also suggest that there are distinct brain–behaviour relationships for different ICF dimensions of sensorimotor behaviour. Chronic motor impairment, as measured by the FMA-UE, was associated with a smaller ipsilesional putamen and larger ipsilesional ventricle, which may provide an indication of corticostriatal circuit integrity as well as more general brain functions essential for sensorimotor control. In contrast, there were no subcortical associations with activity limitations in the current study, possibly related to the smaller sample size. Activity limitations may also be more strongly related to the integrity or function of distributed regions across whole brain networks rather than subcortical structures,58,59 given that functional performance can be influenced by psychosocial factors to a greater degree than impairment measures.

Findings did not indicate a significant effect of lesioned hemisphere on the relationship between chronic sensorimotor behaviour and spared subcortical volumes. These results are surprising, given that the large majority of patients were likely left hemisphere dominant for motor control, and previous research has identified specialized hemispheric in sensorimotor control after stroke.25 However, previous research has primarily focused on cortical regions and functional activity, rather than subcortical structures. Side of stroke injury may not directly impact sensorimotor relationships with spared subcortical volumes.

Finally, the current results represent the first large-scale, multi-site analysis utilizing harmonized high-resolution brain imaging and behavioural measures in the field of stroke rehabilitation. The fact that the current results, using diverse stroke rehabilitation data, fit with existing literature and reveal new findings is further confirmation that such an approach is not only feasible and effective, but also beneficial for moving the stroke rehabilitation field forward.

Limitations and future directions

A key limitation of pooling multi-site data is inconsistent variables across cohorts, limiting subgroup analyses and reducing the number of included covariates. Models only included the covariates age, sex and intracranial volume; however, many additional demographic variables, such as duration and type of rehabilitation received, handedness, race, educational level and comorbidities, may influence these relationships. Although sex was not a significant covariate in the majority of our analyses, it is also worth noting that previous research has shown that women differ from men in the distribution of risk factors and stroke subtype, stroke severity, and outcomes.60,61 Future work with should more carefully examine the role of sex in post-stroke sensorimotor outcomes. In addition, larger sample sizes for different sensorimotor outcome measures would provide greater support for the current findings. Related, small high-resolution MRI samples (n < 50) at earlier time points of stroke (i.e. ≤7 days, defined as acute20) with sensorimotor behavioural outcomes limited our ability to specifically examine acute brain–behaviour relationships or to examine relationships between impairment versus activity limitations in acute or subacute stroke in the current analysis. The ENIGMA Stroke Recovery Working Group recommends following consensus guidelines for greater harmonization of prospectively collected data to facilitate more precise pooled analyses across all times after stroke.14,62

Lesion overlap with subcortical regions and poor segmentation of subcortical regions due to lesion-induced distortions resulted in a variable sample size for each ROI, potentially limiting the power to detect relationships in regions with smaller samples. Furthermore, exclusion of individuals with lesioned or incorrectly segmented ROIs may have disproportionately excluded individuals with larger lesions, who may be more severely affected. This could have biased the sample towards more mild-to-moderately impaired patients. Future studies using information about the lesions (lesion location, volume, and overlap) derived from accurately segmented lesion masks for each observation could address these issues. In addition to lesion information, additional quantification of neuroimaging markers of intracranial small vessel disease, such as white matter hyperintensities and perivascular spaces, could provide a deeper understanding of the relationship between small vessel disease and the observed results.

Finally, many of these subcortical regions are also critical for and related to post-stroke cognition, mood, sleep, learning and other traits of interest. While this analysis was limited to sensorimotor behavioural measures to maximize available data for analysis, these findings may not be unique to sensorimotor behaviour. Future studies should assess the relationship between these subcortical volumes and additional stroke outcome measures.

Conclusion

This international collaborative analysis revealed significant relationships between post-stroke sensorimotor behaviour and volumetric measures of the residual ipsilesional thalamus, putamen, nucleus accumbens, and lateral ventricle at different times after stroke—brain metrics that may reflect overall brain health and network integrity and could lead to the identification of novel neural targets for stroke rehabilitation.

Supplementary material

Supplementary material is available at Brain Communications online.

Supplementary Material

fcab254_Supplementary_Data

Acknowledgements

The authors thank all of the members of the ENIGMA Stroke Recovery working group, all of the participants, as well as Sophia Thomopoulos for her assistance.

Funding

S.-L.L. was supported by National Institutes of Health (NIH) K01 HD091283; NIH R01 NS115845. N.S. was supported by NIH R56 NS100528. N.J. was supported by NIH R01 AG059874; NIH R01 MH117601. A.B. was supported by National Health and Medical Research Council of Australia GNT1020526; GNT1094974; Heart Foundation Future Leader Fellowship 100784. C.M.B was supported by NIH R21 HD067906; NIH R01 NS090677. W.D.B. was supported by the Health Research Council of New Zealand (09/164R; 14/136). J.M.C was supported by NIH R00 HD091375. A.B.C. was supported by NIH R01 NS076348; IIEP-2250-14. A.N.D. was supported by the Lone Star Stroke Research Consortium. N.E. was supported by Australian Research Council DE180100893. W.F. was supported by NIH P20 GM109040. C.A.H. was supported by NIH P20 GM109040. K.S.H. was supported by National Health and Medical Research Council of Australia #1088449; NIH R01 NS115845. B.H. was supported by National Health and Medical Research Council fellowship (1125054). S.A.K. was supported by VA1IK6RX003075; NIH P20 GM109040. B.K was supported by NIH R01 HD065438; NIH R56 NS100528. H.K. was supported by a BrightFocus Faculty Award. B.J.M. was supported by Canadian Partnership for Stroke Recovery; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council; Brain & Behavior Research Foundation. A.R.-M. was supported by Basque Government Elkartek MODULA; H2020-EIC-FETPROACT-2019 MAIA 951910, Bundesministerium für Bildung und Forschung BMBF AMORSA (FKZ 16SV7754); and the Fortüne-Program of the University of Tübingen (2452-0-0/1). F.P. was supported by the Italian Ministry of Health, Grants RC 2016, 2017, 2018, 2019. K.P.R. was supported by NIH R21 HD067906; NIH R01 NS090677. H.M.S. was supported by NIH R01 NS110696; NIH R01 LM013316; NIH K02 NS104207. N.J.S. was supported by NIH U54 GM104941; NIH P20 GM109040. S.R.S. was supported by the European Research Council (ERC, Grant number 759370). G.S. was supported by Italian Ministry of Health grant RC 15-16-17-18-19-20/A. C.M.S was supported by the Health Research Council of New Zealand. L.T.W. was supported by the South-Eastern Norway Regional Health Authority (2014097, 2015044, 2015073); the Norwegian ExtraFoundation for Health and Rehabilitation (2015/FO5146); the Research Council of Norway (249795, 262372); and the European Research Council under the European Union's Horizon 2020 Research and Innovation program (ERC StG, Grant 802998). G.F.W. was supported by the Department of Veterans Affairs RR&D Program. S.L.W. was supported by NIH R01 NS115845, R01HD095975. S.C.C. was supported by NIH U01 NS086872, R01 NR015591, and R01 HD095457. P.M.T. was supported by NIH U54 EB020403.

Competing interests

N.J. and P.M.T. are MPI of a research grant from Biogen, Inc for work unrelated to the contents of this manuscript. S.C.C. has served as a consultant for Constant Therapeutics, MicroTransponder, Neurolutions, SanBio, Stemedica, Fujifilm Toyama Chemical Co., NeuExcell, Medtronic, and TRCare. M.A.P. has received Research Funding & Travel Grant (Bionic Vision Technologies Pty Ltd) unrelated to the contents of this manuscript.

Glossary

ARAT

Action Research Arm Test

CI

confidence interval

df

degrees of freedom

ENIGMA

Enhancing NeuroImaging Genetics through Meta-Analysis

FMA-UE

Fugl-Meyer Motor Assessment of Upper Extremities

ICF

International Classification of Functioning, Disability, and Health

ICV

intracranial volume

IQR

interquartile range

LHS

left hemisphere stroke

RHS

right hemisphere stroke

ROI

region of interest

SE

standard error

T1w

T1-weighted

WMFT

Wolf Motor Function Test

Appendix

Current ENIGMA Stroke Recovery Working Group Member List (as of 10/05/2021)

Nerisa Banaj, Giuseppe Barisano, Lee Baugh, Adrià Bermudo Gallaguet, Anup Bhattacharya, Bavrina Bigjahan, Michael Borich, Lara Boyd, Amy Brodtmann, Truman Brown, Cathrin Buetefisch, Winston Byblow, Jessica Cassidy, Charalambos Charalambous, Valentina Ciullo, Alison Cloutier, James Cole, Adriana Conforto, Richard Craddock, Steven Cramer, Rosalia Dacosta Aguayo, Julie DiCarlo, Michael Dimyan, Martin Domin, Miranda Donnellly, Adrienne Dula, Matthew Edwardson, Natalia Egorova, Elsa Ermer, Mark Etherton, Wuwei Feng, Kelene Fercho, Jennifer Ferris, Fatemeh Geranmayeh, Chris Gregory, Shahram Hadidchi, Colleen Hanlon, Leticia Hayes, Kathryn Hayward, Jess Holguin, Brenton Hordacre, Darryl Hwang, Neda Jahanshad, Keith Jamison, Julia Juliano, Steven Kautz, Mohamed Salah Khlif, Bokkyu Kim, Hosung Kim, Amy Kuceyeski, Catherine Lang, Jenny Lee, Sook-Lei Liew, David Lin, Jingchun Liu, Bethany Lo, Keith Lohse, Martin Lotze, Bradley MacIntosh, John Margetis, Daniel Margulies, Maria Mataro, Keith McGregor, Feroze Mohamed, Jan Nordvik, Emily Olafson, Alexandre Perera-LLuna, Matthew Petoe, Aaron Phillips, Fabrizio Piras, Sharmila Raju, Ander Ramos-Murguialday, Kate Revill, Pamela Roberts, Andrew Robertson, Jane Rondina, Natalia Rost, Nerses Sanossian, Heidi Schambra, Christian Schranz, Nicolas Schweighofer, Na Jin Seo, Farshid Sepehrband, Mark Shiroishi, Julia Simon, Surjo Soekadar, Gianfranco Spalletta, Shraddha Srivastava, Jill Stewart, Cathy Stinear, Anisha Suri, Myriam Taga, Wai Kwong Tang, Gregory Thielman, Vincent Thijs, Sophia Thomopoulos, Paul Thompson, Daniela Vecchio, Steven Warach, Nick Ward, Emilio Werden, Lars Westlye, Roland Wiest, Carolee Winstein, George Wittenberg, Steven Wolf, Kristin Wong, Chunshui Yu, Artemis Zavaliangos-Petropulu.

Contributor Information

ENIGMA Stroke Recovery Working Group:

Nerisa Banaj, Giuseppe Barisano, Lee Baugh, Adrià Bermudo Gallaguet, Anup Bhattacharya, Bavrina Bigjahan, Michael Borich, Lara Boyd, Amy Brodtmann, Truman Brown, Cathrin Buetefisch, Winston Byblow, Jessica Cassidy, Charalambos Charalambous, Valentina Ciullo, Alison Cloutier, James Cole, Adriana Conforto, Richard Craddock, Steven Cramer, Rosalia Dacosta Aguayo, Julie DiCarlo, Michael Dimyan, Martin Domin, Miranda Donnellly, Adrienne Dula, Matthew Edwardson, Natalia Egorova, Elsa Ermer, Mark Etherton, Wuwei Feng, Kelene Fercho, Jennifer Ferris, Fatemeh Geranmayeh, Chris Gregory, Shahram Hadidchi, Colleen Hanlon, Leticia Hayes, Kathryn Hayward, Jess Holguin, Brenton Hordacre, Darryl Hwang, Neda Jahanshad, Keith Jamison, Julia Juliano, Steven Kautz, Mohamed Salah Khlif, Bokkyu Kim, Hosung Kim, Amy Kuceyeski, Catherine Lang, Jenny Lee, Sook-Lei Liew, David Lin, Jingchun Liu, Bethany Lo, Keith Lohse, Martin Lotze, Bradley MacIntosh, John Margetis, Daniel Margulies, Maria Mataro, Keith McGregor, Feroze Mohamed, Jan Nordvik, Emily Olafson, Alexandre Perera-LLuna, Matthew Petoe, Aaron Phillips, Fabrizio Piras, Sharmila Raju, Ander Ramos-Murguialday, Kate Revill, Pamela Roberts, Andrew Robertson, Jane Rondina, Natalia Rost, Nerses Sanossian, Heidi Schambra, Christian Schranz, Nicolas Schweighofer, Na Jin Seo, Farshid Sepehrband, Mark Shiroishi, Julia Simon, Surjo Soekadar, Gianfranco Spalletta, Shraddha Srivastava, Jill Stewart, Cathy Stinear, Anisha Suri, Myriam Taga, Wai Kwong Tang, Gregory Thielman, Vincent Thijs, Sophia Thomopoulos, Paul Thompson, Daniela Vecchio, Steven Warach, Nick Ward, Emilio Werden, Lars Westlye, Roland Wiest, Carolee Winstein, George Wittenberg, Steven Wolf, Kristin Wong, Chunshui Yu, and Artemis Zavaliangos-Petropulu

References

  • 1. Krakauer JW, Carmichael ST.. Broken movement: The neurobiology of motor recovery after stroke. Cambridge, Massachusetts: MIT Press; 2017. [Google Scholar]
  • 2. Hibar DP, Stein JL, Renteria ME, et al. Common genetic variants influence human subcortical brain structures. Nature. 2015;520(7546):224–229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Binkofski F, Seitz R, Arnold S, Classen J, Benecke R, Freund HJ.. Thalamic metabolism and corticospinal tract integrity determine motor recovery in stroke. Ann Neurol. 1996;39(4):460–470. [DOI] [PubMed] [Google Scholar]
  • 4. Fries W, Danek A, Scheidtmann K, Hamburger C.. Motor recovery following capsular stroke: Role of descending pathways from multiple motor areas. Brain. 1993;116(2):369–382. [DOI] [PubMed] [Google Scholar]
  • 5. Shelton FN, Reding MJ.. Effect of lesion location on upper limb motor recovery after stroke. Stroke. 2001;32(1):107–112. [DOI] [PubMed] [Google Scholar]
  • 6. Kuceyeski A, Navi BB, Kamel H, et al. Structural connectome disruption at baseline predicts 6‐months post‐stroke outcome. Hum Brain Mapp. 2016;37(7):2587–2601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Jones EG. The thalamus. New York: Springer Science & Business Media; 2012. [Google Scholar]
  • 8. Carmichael ST, Tatsukawa K, Katsman D, Tsuyuguchi N, Kornblum HI.. Evolution of diaschisis in a focal stroke model. Stroke. 2004;35(3):758–763. [DOI] [PubMed] [Google Scholar]
  • 9. Alexander GE, Crutcher MD, DeLong MR.. Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, “prefrontal” and “limbic” functions. Prog Brain Res. 1991;85:119–146. [PubMed] [Google Scholar]
  • 10. Lanciego JL, Luquin N, Obeso JA.. Functional neuroanatomy of the basal ganglia. Cold Spring Harb Perspect Med. 2012;2(12):a009621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Boyd LA, Winstein CJ.. Providing explicit information disrupts implicit motor learning after basal ganglia stroke. Learn Mem. 2004;11(4):388–396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Campbell BC, Ma H, Ringleb PA, et al. Extending thrombolysis to 4· 5–9 h and wake-up stroke using perfusion imaging: A systematic review and meta-analysis of individual patient data. Lancet. 2019;394(10193):139–147. [DOI] [PubMed] [Google Scholar]
  • 13. Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723–1731. [DOI] [PubMed] [Google Scholar]
  • 14. Liew S-L, Zavaliangos-Petropulu A, Jahanshad N, et al. The enigma stroke recovery working group: Big data neuroimaging to study brain-behavior relationships after stroke. Hum Brain Mapp. 2020:1–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Ioannidis J. Next-generation systematic reviews: Prospective meta-analysis, individual-level data, networks and umbrella reviews. Br J Sports Med. 2017;51(20):1456–1458. [DOI] [PubMed] [Google Scholar]
  • 16. Berlin JA, Santanna J, Schmid CH, Szczech LA, Feldman HI; Anti-Lymphocyte Antibody Induction Therapy Study Group. Individual patient‐versus group‐level data meta‐regressions for the investigation of treatment effect modifiers: Ecological bias rears its ugly head. Stat Med. 2002;21(3):371–387. [DOI] [PubMed] [Google Scholar]
  • 17. Glasziou P, Altman DG, Bossuyt P, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet. 2014;383(9913):267–276. [DOI] [PubMed] [Google Scholar]
  • 18. Apostolova LG, Green AE, Babakchanian S, et al. Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment and Alzheimer's disease. Alzheimer Dis Assoc Disord. 2012;26(1):17–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Hijdra A, Verbeeten B.. Leukoaraiosis and ventricular enlargement in patients with ischemic stroke. Stroke. 1991;22(4):447–450. [DOI] [PubMed] [Google Scholar]
  • 20. Bernhardt J, Hayward KS, Kwakkel G, et al. Agreed definitions and a shared vision for new standards in stroke recovery research: The stroke recovery and rehabilitation roundtable taskforce. Int J Stroke. 2017;12(5):444–450. [DOI] [PubMed] [Google Scholar]
  • 21. Egorova N, Liem F, Hachinski V, Brodtmann A.. Predicted brain age after stroke. Front Aging Neurosci. 2019;11:348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Azari NP, Binkofski F, Pettigrew KD, Freund HJ, Seitz RJ.. Enhanced regional cerebral metabolic interactions in thalamic circuitry predicts motor recovery in hemiparetic stroke. Hum Brain Mapp. 1996;4(4):240–253. [DOI] [PubMed] [Google Scholar]
  • 23. Gauthier LV, Taub E, Mark VW, Barghi A, Uswatte G.. Atrophy of spared gray matter tissue predicts poorer motor recovery and rehabilitation response in chronic stroke. Stroke. 2012;43(2):453–457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. McDougall J, Wright V, Rosenbaum P.. The ICF model of functioning and disability: Incorporating quality of life and human development. Dev Neurorehabil. 2010;13(3):204–211. [DOI] [PubMed] [Google Scholar]
  • 25. Sainburg RL, Maenza C, Winstein C, Good D.. Motor lateralization provides a foundation for predicting and treating non-paretic arm motor deficits in stroke. In: Laczko J., Latash M. (eds) Progress in Motor Control. Advances in Experimental Medicine and Biology, vol 957. Cham: Springer; 2016:257–272. 10.1007/978-3-319-47313-0_14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33(3):341–355. [DOI] [PubMed] [Google Scholar]
  • 27. Fugl-Meyer AR, Jaasko L, Leyman I, Olsson S, Steglind S.. The post-stroke hemiplegic patient. 1. A method for evaluation of physical performance. Scand J Rehabil Med. 1975;7(1):13–31. [PubMed] [Google Scholar]
  • 28. Lyle RC. A performance test for assessment of upper limb function in physical rehabilitation treatment and research. Int J Rehabil Res. 1981;4(4):483–492. [DOI] [PubMed] [Google Scholar]
  • 29. Wolf SL, Catlin PA, Ellis M, Archer AL, Morgan B, Piacentino A.. Assessing wolf motor function test as outcome measure for research in patients after stroke. Stroke. 2001;32(7):1635–1639. [DOI] [PubMed] [Google Scholar]
  • 30. Nieuwenhuis R, Te Grotenhuis H, Pelzer B.. Influence. Me: Tools for detecting influential data in mixed effects models. R-Journal. 2012;4:38–47. [Google Scholar]
  • 31. Greco L, Luta G, Krzywinski M, Altman N.. Analyzing outliers: Robust methods to the rescue. Nat Methods. 2019;16(4):275–277. [DOI] [PubMed] [Google Scholar]
  • 32. Team RC. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2020. [Google Scholar]
  • 33. Pinheiro JB, DebRoy S, Sarkar D.. R Core Team. _nlme: Linear and nonlinear mixed effects models_. R Package Version. 2020;3:1–149. [Google Scholar]
  • 34. Koller M. Robustlmm: An r package for robust estimation of linear mixed-effects models. J Stat Softw. 2016;75(6):1–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Kassambara A. Rstatix: Pipe-friendly framework for basic statistical tests. 2019. https://cran.rproject.org/package=rstatix.
  • 36. Nieuwenhuis R, Te Grotenhuis H, Pelzer B. Influence. Me: Tools for detecting influential data in mixed effects models. 2012. https://repository.ubn.ru.nl/handle/2066/103101
  • 37. Wickham H, Francois R, Henry L, Müller K. Dplyr: A grammar of data manipulation. R package version 1.0.2. 2020.
  • 38. Wickham H, Averick M, Bryan J, et al. Welcome to the tidyverse. J Open Source Softw. 2019;4(43):1686. [Google Scholar]
  • 39. Brodtmann A, Khlif MS, Egorova N, Veldsman M, Bird LJ, Werden E.. Dynamic regional brain atrophy rates in the first year after ischemic stroke. Stroke. 2020;51(9):e183–e192. [DOI] [PubMed] [Google Scholar]
  • 40. Ward NS. Restoring brain function after stroke—bridging the gap between animals and humans. Nat Rev Neurol. 2017;13(4):244–255. [DOI] [PubMed] [Google Scholar]
  • 41. Murphy TH, Corbett D.. Plasticity during stroke recovery: From synapse to behaviour. Nat Rev Neurosci. 2009;10(12):861–872. [DOI] [PubMed] [Google Scholar]
  • 42. Mahajan KR, Nakamura K, Cohen JA, Trapp BD, Ontaneda D.. Intrinsic and extrinsic mechanisms of thalamic pathology in multiple sclerosis. Ann Neurol. 2020;88(1):81–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Arboix A, García-Plata C, García-Eroles L, et al. Clinical study of 99 patients with pure sensory stroke. J Neurol. 2005;252(2):156–162. [DOI] [PubMed] [Google Scholar]
  • 44. Alexander LD, Black SE, Patterson KK, Gao F, Danells CJ, McIlroy WE.. Association between gait asymmetry and brain lesion location in stroke patients. Stroke. 2009;40(2):537–544. [DOI] [PubMed] [Google Scholar]
  • 45. Lee KB, Kim JS, Hong BY, Kim YD, Hwang BY, Lim SH.. The motor recovery related with brain lesion in patients with intracranial hemorrhage. Behav Neurol. 2015;2015:258161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Cheung DK, Climans SA, Black SE, Gao F, Szilagyi GM, Mochizuki G.. Lesion characteristics of individuals with upper limb spasticity after stroke. Neurorehabil Neural Repair. 2016;30(1):63–70. [DOI] [PubMed] [Google Scholar]
  • 47. Baudat C, Maréchal B, Corredor-Jerez R, et al. Automated MRI-based volumetry of basal ganglia and thalamus at the chronic phase of cortical stroke. Neuroradiology. 2020;62(11):1371–1380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Lopes MA, Firbank MJ, Widdrington M, Blamire AM, Kalaria RT, O'Brien J.. Post-stroke dementia: The contribution of thalamus and basal ganglia changes. Int Psychogeriatr. 2012;24(4):568–576. [DOI] [PubMed] [Google Scholar]
  • 49. Luo X, Mao Q, Shi J, Wang X, Li CSR.. Putamen gray matter volumes in neuropsychiatric and neurodegenerative disorders. World J Psychiatry Mental Health Res. 2019;3:1020. [PMC free article] [PubMed] [Google Scholar]
  • 50. de Jong LW, van der Hiele K, Veer IM, et al. Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: An MRI study. Brain. 2008;131(Pt 12):3277–3285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Shin LM, Liberzon I.. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology. 2010;35(1):169–191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Robbins TW, Everitt BJ.. Functions of dopamine in the dorsal and ventral striatum. Semin Neurosci. 1992;4(2):119–127. [Google Scholar]
  • 53. Rochat L, Van der Linden M, Renaud O, et al. Poor reward sensitivity and apathy after stroke: Implication of basal ganglia. Neurology. 2013;81(19):1674–1680. [DOI] [PubMed] [Google Scholar]
  • 54. Widmer M, Lutz K, Luft AR.. Reduced striatal activation in response to rewarding motor performance feedback after stroke. Neuroimage Clin. 2019;24:102036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Sawada M, Kato K, Kunieda T, et al. Function of the nucleus accumbens in motor control during recovery after spinal cord injury. Science. 2015;350(6256):98–101. [DOI] [PubMed] [Google Scholar]
  • 56. Gower A, Tiberi M.. The intersection of central dopamine system and stroke: Potential avenues aiming at enhancement of motor recovery. Front Synaptic Neurosci. 2018;10:18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Förstl H, Zerfass R, Geiger-Kabisch C, Sattel H, Besthorn C, Hentschel F.. Brain atrophy in normal ageing and Alzheimer’s disease. Br J Psychiatry. 1995;167(6):739–746. [DOI] [PubMed] [Google Scholar]
  • 58. van Meer MPA, van der Marel K, Wang K, et al. Recovery of sensorimotor function after experimental stroke correlates with restoration of resting-state interhemispheric functional connectivity. J Neurosci. 2010;30(11):3964–3972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Dong Y, Dobkin BH, Cen SY, Wu AD, Winstein CJ.. Motor cortex activation during treatment may predict therapeutic gains in paretic hand function after stroke. Stroke. 2006;37(6):1552–1555. [DOI] [PubMed] [Google Scholar]
  • 60. Arboix A, Cartanyà A, Lowak M, et al. Gender differences and woman-specific trends in acute stroke: Results from a hospital-based registry (1986–2009). Clin Neurol Neurosurg. 2014;127:19–24. [DOI] [PubMed] [Google Scholar]
  • 61. Bonkhoff AK, Schirmer MD, Bretzner M, et al. ; MRI-GENIE and GISCOME Investigators and the International Stroke Genetics Consortium. Outcome after acute ischemic stroke is linked to sex-specific lesion patterns. Nat Commun. 2021;12(1):1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Kwakkel G, Lannin NA, Borschmann K, et al. Standardized measurement of sensorimotor recovery in stroke trials: Consensus-based core recommendations from the stroke recovery and rehabilitation roundtable. Neurorehabil Neural Repair. 2017;31(9):784–792. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

fcab254_Supplementary_Data

Data Availability Statement

The deidentified summary data and code that support the findings of this study are available upon reasonable request from the corresponding author. The data are not all publicly available in a repository as they may contain information that could compromise the privacy of research participants. There are also data sharing restrictions imposed by some of the (i) ethical review boards of the participating sites, and consent documents; (ii) national and trans-national data sharing laws; and (iii) institutional processes, some of which require a signed data transfer agreement for limited and predefined data use. However, we welcome sharing data with researchers, requiring that they become members of the ENIGMA Stroke Recovery working group and submit an analysis plan for a secondary project for group review. Once this analysis plan is approved, access to the relevant data will be provided contingent on data availability, local PI approval and compliance with all supervening regulatory boards.


Articles from Brain Communications are provided here courtesy of Oxford University Press

RESOURCES